Literature DB >> 8021137

Locally invasive papillary thyroid carcinoma: 1940-1990.

T V McCaffrey1, E J Bergstralh, I D Hay.   

Abstract

Well-differentiated thyroid carcinoma infrequently invades the upper aerodigestive tract. However, when invasion occurs, it is the source of significant morbidity. The most common structures invaded by thyroid carcinoma are the recurrent laryngeal nerves, larynx, pharynx, and esophagus. Invasion of these structures produces symptoms of airway insufficiency, dysphagia, and hemoptysis. This study was designed to define more clearly the significance of invasion of papillary thyroid carcinoma on survival. At the Mayo Clinic, 262 patients treated for invasive papillary thyroid carcinoma between 1940 and 1990 were retrospectively evaluated. In this group the sites of invasion were muscle 53%, trachea 37%, laryngeal nerve 47%, esophagus 21%, larynx 12%, and other sites 30%. Complete tumor removal was accomplished in 56% of cases. Kaplan-Meier survival curves were calculated for the population. The overall survival was 79% at 5 years, 63% at 10 years, and 54% at 15 years. When the Cox proportional hazard model was applied to the survival data, the factors that had significant influence on survival were invasion of the trachea and the esophagus. Completeness of resection approached statistical significance. Muscle invasion, laryngeal invasion, and recurrent laryngeal nerve invasion had no significant independent influence on survival. These data suggest that when papillary thyroid carcinoma extends beyond the thyroid capsule and invades adjacent structures, the site invaded will influence survival. Survival may be improved in those cases in which complete surgical excision of the tumor is performed.

Entities:  

Mesh:

Year:  1994        PMID: 8021137     DOI: 10.1002/hed.2880160211

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  46 in total

1.  MR imaging for predicting neoplastic invasion of the cervical esophagus.

Authors:  S Roychowdhury; L A Loevner; D M Yousem; A Chalian; K T Montone
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

Review 2.  The management of metastatic differentiated thyroid carcinoma.

Authors:  S I Sherman
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

3.  Modern imaging of the tracheo-bronchial tree.

Authors:  Archana T Laroia; Brad H Thompson; Sandeep T Laroia; Edwin van Beek
Journal:  World J Radiol       Date:  2010-07-28

4.  Surgical decision making in the management of well-differentiated thyroid cancer.

Authors:  Natalya Chernichenko; Ashok R Shaha
Journal:  Indian J Surg Oncol       Date:  2012-05-01

Review 5.  An evidence-based review of poorly differentiated thyroid cancer.

Authors:  Enoch M Sanders; Virginia A LiVolsi; James Brierley; Jennifer Shin; Gregory W Randolph
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

6.  Phonatory function in patients with well-differentiated thyroid carcinoma following meticulous resection of tumors adhering to the recurrent laryngeal nerve.

Authors:  Satoru Miyamaru; Yoshihiko Kumai; Daizo Murakami; Narihiro Kodama; Takumi Miyamoto; Eiji Yumoto; Yorihisa Orita
Journal:  Int J Clin Oncol       Date:  2019-06-24       Impact factor: 3.402

Review 7.  Exploiting biology in selecting treatment for differentiated cancer of the thyroid gland.

Authors:  Jatin P Shah
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-11       Impact factor: 2.503

8.  Classification of aerodigestive tract invasion from thyroid cancer.

Authors:  Michael Brauckhoff
Journal:  Langenbecks Arch Surg       Date:  2013-11-24       Impact factor: 3.445

9.  Segmental tracheal resection for invasive differentiated thyroid carcinoma. Our experience in eight cases.

Authors:  Claudio Mossetti; Nicola Palestini; Maria Cristina Bruna; Michele Camandona; Milena Freddi; Alberto Oliaro; Guido Gasparri
Journal:  Langenbecks Arch Surg       Date:  2013-12       Impact factor: 3.445

10.  Inter-Observer Variation in the Pathologic Identification of Minimal Extrathyroidal Extension in Papillary Thyroid Carcinoma.

Authors:  Henry K Su; Bruce M Wenig; Grace C Haser; Meghan E Rowe; Sylvia L Asa; Zubair Baloch; Eugenie Du; William C Faquin; Giovanni Fellegara; Thomas Giordano; Ronald Ghossein; Virginia A LiVolsi; Ricardo Lloyd; Ozgur Mete; Umut Ozbek; Juan Rosai; Saul Suster; Lester D Thompson; Andrew T Turk; Mark L Urken
Journal:  Thyroid       Date:  2016-04       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.